Moody's: Outlook For Global Pharmaceuticals Stable Despite Growing Anger

Moody’s expects global pharmaceuticals to be stable in 2017, as cost pressures neutralize gains from rising demand, and modest price increases in U.S. offset single-digit declines in rest of the world and despite growing anger over increasing drug costs. The outlook for the medical device industry and for-profit hotel chains was also rated stable.

Healthcare will account for a larger share of GDP in most countries, as demographics, including aging populations, continue to . . .


This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email and we will get back to you as quick as humanly possible

Subscribe to our mailing list

* indicates required

Opt out of occasional 3rd party offers